Teva Can't Escape Investors' Price-Fixing Claims, Judge Says
Teva Pharmaceutical Industries Ltd. will continue to face investors' proposed class claims that it misled them by telling them its revenue was increasing because of efficiency and good management while the...To view the full article, register now.
Already a subscriber? Click here to view full article